Markets capitulate but a respite is in sight

Markets capitulate but a respite is in sightMarkets capitulate but a respite is in sight

ETFS Multi-Asset Weekly – Markets capitulate but a respite is in sight

Download the complete report (.pdf)

Highlights

•    Oversupply pulls oil benchmarks to their lowest in 3 months.
•    Chinese authorities show determination in arresting market capitulation.
•    Commodity currencies depreciate on commodity market correction.

We are unlikely to see an end to Greek saga this week, dramatic or otherwise. The deal announced this morning still needs to be approved by the Greek parliament. Given the staunch opposition to further austerity and rigorous monitoring we are likely to see further rounds of arduous negotiations. Chinese equities capped losses with 2 days of positive trading toward the end of last week, but the negative sentiment around the country’s performance has weighed on commodity prices as China remains the largest consumer of almost all commodities.

Commodities

Oversupply pulls oil benchmarks to their lowest in 3 months. Rising rig counts in the US, continued increase in OPEC oil production and a general lack of investment cuts by producers has kept global oil supply elevated. As we have long argued, the rebound in oil prices since March was unsustainable without supply cuts. In the past week WTI has fallen by 7.3% and Brent by 5.6%. These price declines are necessary to motivate producers to reduce output and move the market closer to balance. The International Energy Agency this week projects that the rebalancing process will extend well into 2016. Iranian nuclear discussions have seen another deadline missed without a final verdict but talks continue to press on. If sanctions against Iran are successfully lifted, more oil supply is likely to hit the market next year, making the job of cutting back on production elsewhere that more pressing.

Equities

Chinese authorities show determination in arresting market capitulation. After falling 35% between 12th June and 7th July, MSCI China A-Shares rose 5.8% on the 8th and 4.5% on the 9th July. One of the factors driving the initial fall was a tightening on margin financing. However, with the sharp decline in prices, the central bank used the China Securities Finance Corp, the state agency responsible for margin financing loan services to qualified securities companies, to inject funding into the equity market. Additionally the Chinese authorities are investigating claims of “malicious” short selling. The broader slowdown in economic growth in China is likely to be met with further interest rate cuts and other measures to ensure ample access to financing. The government has considerable resources to see that its reform agenda is not derailed by financial market woes or a sharp slowdown in the economy. The equity market will likely respond positively to the deployment of further easing.

Currencies

Commodity currencies depreciate on commodity market correction. Australian Dollar (AUD) fell 2.7%, Norwegian Krone (NOK) fell 2.0% and New Zealand Dollar (NZD) fell 1.5% against the US Dollar as commodity fell sharply in the week. While oil prices may fall further to drive the necessary rebalancing of supply, other commodities are likely to rebound as prices are currently divorced from fundamentals. In the near-term NOK will continue to feel the pressure of lower oil prices, but AUD and NZD are likely to benefit from China’s expansionary policies that will likely lift the excessively negative sentiment in other cyclical commodities. The Bank of Canada will have a policy meeting this week. Economists surveyed by Bloomberg show 14 expect a cut while 13 expect rates to be maintained. Given the divided opinion, we believe CAD could be a key mover this week.

For more information contact:

ETF Securities Research team
ETF Securities (UK) Limited
T +44 (0) 207 448 4336
E  info@etfsecurities.com

Important Information

General

This communication has been issued and approved for the purpose of section 21 of the Financial Services and Markets Act 2000 by ETF Securities (UK) Limited (”ETFS UK”) which is authorised and regulated by the United Kingdom Financial Conduct Authority (”FCA”).

Investments may go up or down in value and you may lose some or all of the amount invested.  Past performance is not necessarily a guide to future performance. You should consult an independent investment adviser prior to making any investment in order to determine its suitability to your circumstances.

The information contained in this communication is for your general information only and is neither an offer for sale nor a solicitation of an offer to buy securities. This communication should not be used as the basis for any investment decision. Historical performance is not an indication of future performance and any investments may go down in value.

This communication may contain independent market commentary prepared by ETFS UK based on publicly available information. Although ETFS UK endeavours to ensure the accuracy of the content in this communication, ETFS UK does not warrant or guarantee its accuracy or correctness. Any third party data providers used to source the information in this communication make no warranties or representation of any kind relating to such data. Where ETFS UK has expressed its own opinions related to product or market activity, these views may change. Neither ETFS UK, nor any affiliate, nor any of their respective, officers, directors, partners, or employees accepts any liability whatsoever for any direct or consequential loss arising from any use of this publication or its contents.

ETFS UK is required by the FSA to clarify that it is not acting for you in any way in relation to the investment or investment activity to which this communication relates. In particular, ETFS UK will not provide any investment services to you and or advise you on the merits of, or make any recommendation to you in relation to, the terms of any transaction.  No representative of ETFS UK is authorised to behave in any way which would lead you to believe otherwise. ETFS UK is not, therefore, responsible for providing you with the protections afforded to its clients and you should seek your own independent legal, investment and tax or other advice as you see fit.

This document is not, and under no circumstances is to be construed as, an advertisement or any other step in furtherance of a public offering of shares or securities in the United States or any province or territory thereof. Neither this document nor any copy hereof should be taken, transmitted or distributed (directly or indirectly) into the United States.

Other than as set out above, investors may contact ETFS UK at +44 (0)20 7448 4330 or at retail@etfsecurities.com to obtain copies of prospectuses and related regulatory documentation, including annual reports. Other than as separately indicated, this communication is being made on a ”private placement” basis and is intended solely for the professional / institutional recipient to which it is delivered.

Third Parties

Securities issued by each of the Issuers are direct, limited recourse obligations of the relevant Issuer alone and are not obligations of or guaranteed by any of UBS AG, Merrill Lynch Commodities Inc. (”MLCI”), Bank of America Corporation (”BAC) or any of their affiliates. UBS AG, MLCI and BAC, Shell Trading Switzerland, Shell Treasury, HSBC Bank USA N.A., JP Morgan Chase Bank, N.A., Deutsche Bank AG any of their affiliates or anyone else or any of their affiliates. Each of UBS AG, Merrill Lynch Commodities Inc. (”MLCI”), Bank of America Corporation (”BAC) or any of their affiliates. UBS AG, MLCI and BAC, Shell Trading Switzerland, Shell Treasury, HSBC Bank USA N.A., JP Morgan Chase Bank, N.A. and Deutsche Bank AG disclaims all and any liability whether arising in tort, contract or otherwise (save as referred to above) which it might have in respect of this document or its contents otherwise arising in connection herewith.

”Dow Jones,” ”UBS”, DJ-UBS CISM,”, ”DJ-UBS CI-F3SM,” and any related indices or sub-indices are service marks of Dow Jones Trademark Holdings LLC (”Dow Jones”), CME Group Index Services LLC (”CME Indexes”), UBS AG (”UBS”) or UBS Securities LLC (”UBS Securities”), as the case may be, and have been licensed for use by the Issuer. The securities issued by CSL although based on components of the Dow Jones UBS Commodity Index 3 month ForwardSM are not sponsored, endorsed, sold or promoted by Dow Jones, CME Indexes, UBS, UBS Securities or any of their respective subsidiaries or affiliates, and none of Dow Jones, CME Indexes, UBS, UBS Securities, or any of their respective subsidiaries or affiliates, makes any representation regarding the advisability of investing in such product.